Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients

This study has been completed.
Information provided by:
Deutsches Herzzentrum Muenchen Identifier:
First received: September 13, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
The purpose of this study was to investigate differences in risk prediction in female post-infarction patients.

Myocardial Infarction

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients

Further study details as provided by Deutsches Herzzentrum Muenchen:

Estimated Enrollment: 750
Study Start Date: January 1995

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

acute myocardial infarction; female gender

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00196287

Deutsches Herzzentrum Muenchen
Munich, Germany, 80636
1. Medizinische Klinik, Klinikum rechts der Isar
Munich, Germany, 81675
Sponsors and Collaborators
Deutsches Herzzentrum Muenchen
Study Chair: Georg Schmidt, MD Deutsches Herzzentrum Muenchen
Study Director: Petra Barthel, MD Deutsches Herzzentrum Muenchen
Principal Investigator: Axel Bauer, MD Deutsches Herzzentrum Muenchen
  More Information

Additional Information:
Publications: Identifier: NCT00196287     History of Changes
Other Study ID Numbers: GE IDE No. R00395 
Study First Received: September 13, 2005
Last Updated: September 13, 2005
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Keywords provided by Deutsches Herzzentrum Muenchen:
Assessment, risk
autonomic nervous system

Additional relevant MeSH terms:
Myocardial Infarction
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases processed this record on October 21, 2016